Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Stage I-II Nodular Lymphocyte-Predominant Hodgkin Lymphoma: a Multi-institutional Experience of Adult Patients by ILROG.

Binkley MS, Rauf MS, Milgrom SA, Pinnix CC, Tsang RW, Dickinson M, Ng A, Roberts KB, Gao S, Balogh AG, Ricardi U, Levis M, Casulo C, Stolten M, Specht L, Plastaras JP, Wright C, Kelsey CR, Brady JL, Mikhaeel NG, Hoppe BS, Terezakis S, Picardi M, Della Pepa R, Kirova Y, Akhtar S, Maghfoor I, Koenig JL, Jackson C, Song E, Sehgal S, Advani R, Natkunam Y, Constine LS, Eich HT, Wirth A, Hoppe RT.

Blood. 2020 Mar 25. pii: blood.2019003877. doi: 10.1182/blood.2019003877. [Epub ahead of print]

PMID:
32211877
2.

Translation and validation of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) version 4 quality of life instrument into Arabic language.

Soudy H, Maghfoor I, Elhassan TAM, Abdullah E, Rauf SM, Al Zahrani A, Akhtar S.

Health Qual Life Outcomes. 2018 Mar 12;16(1):47. doi: 10.1186/s12955-018-0861-7.

3.

Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplant.

Elshenawy MA, Shahzad Rauf M, Elhassan TAM, Maghfoor I, Akhtar S.

Ann Hematol. 2018 Jul;97(7):1229-1240. doi: 10.1007/s00277-018-3283-z. Epub 2018 Feb 26.

PMID:
29484455
4.

Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.

Akhtar S, Rauf SM, Elhassan TA, Maghfoor I.

Ann Hematol. 2016 Sep;95(9):1521-35. doi: 10.1007/s00277-016-2736-5. Epub 2016 Jul 4.

PMID:
27376363
5.

High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma.

Akhtar S, Elhassan TAM, Edesa W, Rauf MS, Zahir MN, Maghfoor I.

Ann Hematol. 2016 Jan;95(1):49-54. doi: 10.1007/s00277-015-2527-4.

PMID:
26467917
6.

Prevalence of menstrual cycles and outcome of 50 pregnancies after high-dose chemotherapy and auto-SCT in non-Hodgkin and Hodgkin lymphoma patients younger than 40 years.

Akhtar S, Youssef I, Soudy H, Elhassan TA, Rauf SM, Maghfoor I.

Bone Marrow Transplant. 2015 Dec;50(12):1551-6. doi: 10.1038/bmt.2015.178. Epub 2015 Aug 3.

7.

Changing trends of adult lymphoma in the Kingdom of Saudi Arabia - comparison of data sources.

Rauf MS, Akhtar S, Maghfoor I.

Asian Pac J Cancer Prev. 2015;16(5):2069-72.

8.

High-dose chemotherapy and auto-SCT for relapsed and refractory Hodgkin's lymphoma patients refractory to first-line salvage chemotherapy but responsive to second-line salvage chemotherapy.

Rauf MS, Maghfoor I, Elhassan TA, Akhtar S.

Med Oncol. 2015 Jan;32(1):388. doi: 10.1007/s12032-014-0388-7. Epub 2014 Nov 28.

PMID:
25429839
9.

The utility of online haemodiafiltration in methotrexate poisoning.

Abdelsalam MS, Althaf MM, Alfurayh O, Maghfoor I.

BMJ Case Rep. 2014 May 23;2014. pii: bcr2014203530. doi: 10.1136/bcr-2014-203530.

10.

Upper aero-digestive tract lymphomas presenting as polypoidal/pedunculated lesions: case report and review of literature.

Akhtar S, Rana TA, Aldei A, Maghfoor I, Almutawa AM.

Head Neck Pathol. 2014;8(3):317-21. doi: 10.1007/s12105-013-0498-0. Epub 2013 Oct 23. Review.

11.

Local recurrence of primary central nervous system lymphoma due to tumor seeding.

Madkhali I, Bakshi N, Akhtar S, Maghfoor I.

Ann Saudi Med. 2013 May-Jun;33(3):310-1. doi: 10.5144/0256-4947.2013.310. No abstract available.

12.

Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and auto-SCT.

Akhtar S, Al-Sugair AS, Abouzied M, Alkadhi Y, Dingle M, Abdelsalam M, Soudy H, Darwish A, Eltigani A, Elhassan TA, Nabil-Ahmed M, Maghfoor I.

Bone Marrow Transplant. 2013 Nov;48(12):1530-6. doi: 10.1038/bmt.2013.88. Epub 2013 Jun 10.

PMID:
23749108
13.

Pre-transplant (18)F-fluorodeoxyglucose positron emission tomography-based survival model in patients with aggressive lymphoma undergoing high-dose chemotherapy and autologous SCT.

Akhtar S, Al-Sugair AS, Abouzied M, Alkadhi Y, Dingle M, Abdelsalam M, Soudy H, Darwish A, Eltigani A, Elhassan TA, Nabil-Ahmed M, Maghfoor I.

Bone Marrow Transplant. 2013 Apr;48(4):551-6. doi: 10.1038/bmt.2012.168. Epub 2012 Sep 10.

PMID:
22964592
14.

The current lymphoma classification: new concepts and practical applications triumphs and woes.

Bakshi N, Maghfoor I.

Ann Saudi Med. 2012 May-Jun;32(3):296-305. doi: 10.5144/0256-4947.2012.296. Review.

15.

Untreated primary thyroid lymphoma in an elderly woman.

Akhtar S, Bakshi N, Janabi I, Samar S, Maghfoor I.

Hematol Oncol Stem Cell Ther. 2011;4(2):103-4. No abstract available.

16.

Successful treatment of steroid-refractory autoimmune thrombocytopenia associated with Castleman disease with anti-CD-20 antibody (rituximab).

Ibrahim K, Maghfoor I, Elghazaly A, Bakshi N, Mohamed SY, Aljurf M.

Hematol Oncol Stem Cell Ther. 2011;4(2):100-2.

17.

Improved survival with combined chemo-radiotherapy in primary central nervous system lymphoma.

Abdelsalam M, El-Husseiny G, Akhtar S, Khafaga Y, Al-Shabana M, AlHusaini H, El Weshi A, Rahal M, Maghfoor I.

Hematol Oncol Stem Cell Ther. 2010;3(3):128-34.

18.

High-dose chemotherapy and autologous stem cell transplant in adolescent patients with relapsed or refractory Hodgkin's lymphoma.

Akhtar S, El Weshi A, Rahal M, Abdelsalam M, Al Husseini H, Maghfoor I.

Bone Marrow Transplant. 2010 Mar;45(3):476-82. doi: 10.1038/bmt.2009.197. Epub 2009 Sep 7.

PMID:
19734949
19.

High-dose chemotherapy and autologous stem cell transplantation for Hodgkin's lymphoma in the kingdom of Saudi Arabia: King Faisal specialist hospital and research center experience.

Akhtar S, Abdelsalam M, El Weshi A, Al Husseini H, Janabi I, Rahal M, Maghfoor I.

Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S37-S40. doi: 10.1038/bmt.2008.111.

PMID:
18724297
20.

Successful outcome of Langerhans cell histiocytosis complicated by therapy-related myelodysplasia and acute myeloid leukemia: a case report.

Al-Anazi KA, Alshehri A, Al-Zahrani HA, Al-Mohareb FI, Maghfoor I, Ajarim D.

Cases J. 2008 Aug 18;1(1):101. doi: 10.1186/1757-1626-1-101.

Supplemental Content

Loading ...
Support Center